Dalteparin sodium injection (Fragmin, Eisai/Pfizer) is now approved for the extended treatment of symptomatic venous thromboembolism (VTE) (proximal deep vein thrombosis [DVT]), or pulmonary embolism (PE) to reduce the recurrence of VTE in patients with cancer. VTE is a common medical complication in immobilized patients. During a six-month period, nearly twice as many patients treated [...]
A tablet made by Novartis combines two agents used to treat hypertension: valsartan (Generic Diovan), an angiotensin-receptor blocker (ARB), and amlodipine (Norvasc tablet), a calcium-channel blocker (CCB). Both drugs allow blood vessels to relax so that blood can flow more easily. The FDA’s approval was supported by a clinical program involving more than 5,000 patients. [...]
Ezetimibe and simvastatin drug together were more effective in lowering low-density lipoprotein-cholesterol (LDL-C) and C-reactive protein (CRP) levels, compared with either drug as monotherapy, say researchers from University of Rochester, New York, and Methodist DeBakey Heart Center and Baylor College of Medicine in Houston, Texas. In three identical prospective trials, patients were randomly assigned to [...]
